Seung-Soo Han

Title: Seung-Soo Han: Innovator in Dendritic Cell Research

Introduction

Seung-Soo Han is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of immunotherapy through his innovative research on dendritic cells. With a total of two patents to his name, Han's work focuses on enhancing the immune response for therapeutic applications.

Latest Patents

Han's latest patents include a method for preparing dendritic cells and a composition for maturing these cells. The first patent describes a method that treats dendritic cells at a maturation stage with an antigen bound to a peptide that has cell membrane permeability. This approach aims to improve the antigen-presenting ability of dendritic cells, making them more effective for use in anti-tumor vaccines and pharmaceutical compositions for treating tumors. The second patent outlines a composition for maturing dendritic cells, which includes various maturation-promoting factors such as Interleukin-1β, Interleukin-6, and Tumor necrosis factor-α. This composition not only enhances the ability of dendritic cells to induce an immune response but also optimizes the antigen-specific immune response, thereby maximizing the effects of immunotherapy.

Career Highlights

Seung-Soo Han is currently associated with Jw Creagene Inc., where he continues to advance his research in dendritic cell technology. His work has positioned him as a key figure in the field of immunotherapy, contributing to the development of innovative treatments for cancer.

Collaborations

Han collaborates with notable colleagues such as Young-Mok Kim and Yong-Soo Bae, who share his commitment to advancing research in immunotherapy and dendritic cell applications.

Conclusion

Seung-Soo Han's innovative work in dendritic cell research has the potential to significantly impact the field of immunotherapy. His patents reflect a deep understanding of immune response mechanisms and a commitment to developing effective treatments for cancer.